Clinical Trial

Cardiology Research Dubrava Prospective Registry

Study acronym: CaRDr
Recruiting
View on ClinicalTrials.gov →
Summary
Cardiology Research Dubrava registry is a prospective, single centre registry including patients with acute coronary syndrome with and without ST segment elevation, patients with heart failure who were prescribed with SGLT-2 inhibitors, patients implanted with TAVI, patients with venous thromboembolism, patients with pulmonary embolism who underwent thromboaspiration procedure, patients implanted with ICD, CRT and conduction system pacing devices, as well as patients with atrial fibrillation who underwent pulmonary vein isolation and are prescribed with long-term anticoagulation therapy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-13; most recent amendment 2024-03-15.
Trial Details
NCT Number NCT06090591
Lead Sponsor University Hospital Dubrava
Conditions Heart Failure, Arrhythmias, Cardiac, Atrial Fibrillation, Acute Coronary Syndrome
Enrollment 3,000 participants
Start Date 2023-01-01
Primary Completion 2033-01 (estimated)
Study Completion 2033-06 (estimated)
Updated on ClinicalTrials.gov 2024-03-19